Average Co-Inventor Count = 5.22
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (15 from 175 patents)
2. Genentech, Inc. (7 from 3,222 patents)
3. F. Hoffmann-la Roche Ag (2 from 168 patents)
22 patents:
1. 10004748 - Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pictilisib
2. 9855270 - Methods and compositions for modulating estrogen receptor mutants
3. 9335320 - Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
4. 9107926 - Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
5. 8771942 - SCDs as modifiers of the p53 pathway and methods of use
6. 8679763 - EEF2K as modifiers of the PTEN/AKT pathway and methods of use
7. 8604014 - Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use
8. 8536161 - Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
9. 8426147 - RORS as modifiers of the p21 pathway and methods of use
10. 8268548 - MAP3Ks as modifiers of the p53 pathway and methods of use
11. 8247397 - Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
12. 8153384 - Marks as modifiers of the p53 pathway and methods of use
13. 7993829 - HPRP4s modifiers of the p53 pathway and methods of use
14. 7943302 - C20ORF23 as modifier of the IGFR pathway and methods of use
15. 7888048 - P4HAS as modifiers of the IGFR pathway and methods of use